UBS Oncology Impact Fund L.P. - 10%+ Owner at Cullinan Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
CGEM on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by UBS Oncology Impact Fund L.P. since 11/5/2023

Holdings reported by UBS Oncology Impact Fund L.P. for Cullinan Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 7.65M $95.3M $12.46 Sep 16, 2021 Direct

Transactions reported by UBS Oncology Impact Fund L.P. for Cullinan Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.